99 related articles for article (PubMed ID: 3738400)
1. Tamoxifen responders selection by computerized contact thermography in benign breast disease.
Cupceancu B; Mogoş I; Cotruţă C
Endocrinologie; 1986; 24(2):115-22. PubMed ID: 3738400
[TBL] [Abstract][Full Text] [Related]
2. Short-term tamoxifen treatment in benign breast diseases.
Cupceancu B
Endocrinologie; 1985; 23(3):169-77. PubMed ID: 4048817
[TBL] [Abstract][Full Text] [Related]
3. Combined tamoxifen-lynestrenol treatment in benign breast disease.
Cupceancu B
Endocrinologie; 1985; 23(4):265-72. PubMed ID: 4089504
[TBL] [Abstract][Full Text] [Related]
4. The role of tamoxifen in the prevention and treatment of benign and malignant breast lesions: a chemopreventive.
Leis HP
Int Surg; 1993; 78(2):176-82. PubMed ID: 8354620
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of benign breast pathology with bromocriptine].
Tolino A; Cardone A; Mastrantonio P; Chiacchio G
Riv Ital Ginecol; 1977; 58(5):371-8. PubMed ID: 555037
[No Abstract] [Full Text] [Related]
6. [A case of recurrent breast cancer responding to long-term administration of tamoxifen].
Yayoi E; Kobayashi T; Inaji H; Maeura Y; Mori T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1683-6. PubMed ID: 6433801
[TBL] [Abstract][Full Text] [Related]
7. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
[TBL] [Abstract][Full Text] [Related]
9. [Role of cancer thermography for detection of breast cancer].
Yokoe T; Ishida T; Ogawa T; Iino Y; Kawai T; Izuo M
Gan No Rinsho; 1990 Jul; 36(8):885-9. PubMed ID: 2366324
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of tamoxifen in patients with breast cancer: comparison of traditional and loading dose schedules.
Fabian C; Sternson L; Barnett M
Cancer Treat Rep; 1980; 64(6-7):765-73. PubMed ID: 7427961
[TBL] [Abstract][Full Text] [Related]
11. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
Davidson NE; O'Neill AM; Vukov AM; Osborne CK; Martino S; White DR; Abeloff MD
J Clin Oncol; 2005 Sep; 23(25):5973-82. PubMed ID: 16087950
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen effects on treatment fibrocystic breast disease in women.
Mousavi SR; Rezaei M
Saudi Med J; 2006 Apr; 27(4):565-6. PubMed ID: 16598346
[No Abstract] [Full Text] [Related]
13. Tamoxifen therapy in premenopausal women with metastatic breast cancer.
Planting AS; Alexieva-Figusch J; Blonk-vdWijst J; van Putten WL
Cancer Treat Rep; 1985 Apr; 69(4):363-8. PubMed ID: 3995508
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen therapy in premenopausal patients with metastatic breast cancer.
Pritchard KI; Thomson DB; Myers RE; Sutherland DJ; Mobbs BG; Meakin JW
Cancer Treat Rep; 1980; 64(6-7):787-96. PubMed ID: 7427962
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of tamoxifen as treatment of breast cancer.
Powles TJ
Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-48-S1-54. PubMed ID: 9045315
[TBL] [Abstract][Full Text] [Related]
16. The establishment and operation of a computerized data bank in benign breast disease. (Preliminary results on 297 cases).
Cupceancu B; Cotruţă C
Endocrinologie; 1987; 25(3):167-77. PubMed ID: 3685847
[TBL] [Abstract][Full Text] [Related]
17. Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
J Clin Oncol; 2005 Aug; 23(22):5178-87. PubMed ID: 15998905
[TBL] [Abstract][Full Text] [Related]
18. Estimation of StilbostatR treatment efficiency in breast cancer by thermography.
Zimel H; Mogos I; Maltezeanu G
Neoplasma; 1977; 24(5):553-7. PubMed ID: 927612
[TBL] [Abstract][Full Text] [Related]
19. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
Johansen J; Overgaard J; Overgaard M
Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
[TBL] [Abstract][Full Text] [Related]
20. Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
Kaufmann M; Rody A
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):146-54. PubMed ID: 16621229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
